BE study retention sample [Regulatives / Guidelines]

posted by elam – Saudi Arabia, 2015-05-12 12:30 (3561 d 13:42 ago) – Posting: # 14790
Views: 2,324

Dear All,

Here with I am requesting you to clarify my doubt on the BE study retention sample.

As per USFDA, “The quantity of reserve samples should be sufficient to permit the Agency to perform five times all of the release tests required in the application or supplemental application.”

Here the question is five times of the release test means, quantity required for COA or total analytical requirement?

Total analytical requirement means physical evaluation, analytical testing, disso testing, stability requirement, F2 disso profile & analytical testing for COA.

As per EMA, “ the reference sample should be of sufficient size to permit the carrying out, on, at least, two occasions, of the full analytical controls on the batch in accordance with the IMP dossier submitted for authorization to conduct the clinical trial”.

Here the same question is two occasions of the full analytical controls means, quantity required for COA or total analytical requirement?

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
280 visitors (0 registered, 280 guests [including 17 identified bots]).
Forum time: 01:13 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5